The areas of the tumor that displayed “aggressive” features (i.e. myometrial invasion and lymphovascular invasion) all showed a p53-wild-type immunophenotype, which argues against the possibility that the p53-aberrant clone was particularly aggressive. This evidence concerns the gene TP53 and neoplasm.